NYSE: HAE
Haemonetics insiders
The officers, directors and 10% owners of Haemonetics Corporation who hold the most stock, valued at the live HAE price.
$119.89
HAE today −$3.0M (−2.42%)
Live prices, last trade 3:08 PM ET
- Ranked insiders
- 10
- Their HAE stock
- $89.9M
- Market value
- $5.61B
- Held by ranked insiders
- 1.60%
Insiders by value of HAE holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Christopher Simon | President & CEO | 444,704 | $53.3M | 0.95% | 2406th |
| 2 | Michelle L. Basil | EVP and General Counsel | 68,829 | $8.3M | 0.15% | 10181st |
| 3 | James DArecca | EVP, Chief Financial Officer | 54,444 | $6.5M | 0.12% | 11421st |
| 4 | Laurie A. Miller | SVP, Human Resources | 40,987 | $4.9M | <0.1% | 14556th |
| 5 | Robert E. Abernathy | Director | 27,519 | $3.3M | <0.1% | 14144th |
| 6 | Mark W. Kroll | Director | 27,295 | $3.3M | <0.1% | 11811th |
| 7 | Charles Dockendorff | Director | 25,041 | $3.0M | <0.1% | 4942nd |
| 8 | Ellen M. Zane | Director | 21,911 | $2.6M | <0.1% | 10372nd |
| 9 | Catherine M. Burzik | Director | 19,545 | $2.3M | <0.1% | 11551st |
| 10 | Claire Pomeroy | Director | 19,410 | $2.3M | <0.1% | 13596th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Haemonetics; see each profile for the filing.